Plasma neurofilament light (NfL)

DIAGNOSTIC_TEST2 trials

Sponsors

Skane University Hospital

Conditions

Alzheimer DiseaseFrontotemporal DegenerationLewy Body DiseaseMild Cognitive ImpairmentMild DementiaSCDVascular Dementia

Unknown Phase

The Swedish BioFINDER - Primary Care Study

RecruitingNCT06120361

Skane University HospitalAlzheimer Disease, Frontotemporal Degeneration, Lewy Body Disease +4

Start: 2020-01-01End: 2028-12-31Target: 1200Updated: 2026-04-06

The Swedish BioFINDER - Memory Clinic Study

RecruitingNCT06122415

Skane University HospitalAlzheimer Disease, Frontotemporal Degeneration, Lewy Body Disease +4

Start: 2022-12-01End: 2026-12-31Target: 1200Updated: 2026-04-06

Related Papers

Eligibility for amyloid targeting therapies among primary care patients with cognitive symptoms

Alzheimer s Research & Therapy2026-03-21

Assessing Eligibility for Anti‐Amyloid Treatment Among Primary Care Patients with Cognitive Symptoms

Alzheimer s & Dementia2025-12-01